Moreover, according to the KDIGO guideline, we found that the increase in MALAT1 or the decrease in miR‐204 was more evident in stage 3 AKI patients compared with stage 1 or stage 2 groups (Figures 1B and 2B). Here, MALAT1 is linked to acute kidney injury.